Thai vaccine to enter third phase of trials 2021-11-18 Chulalongkorn University’s Centre of Excellence in Vaccine Research and Development expects to register its mRNA Covid-19 vaccine, known as ChulaCOV-19, mid-next year. Source : https://www.bangkokpost.com/thailand/general/2217743/thai-vaccine-to-enter-third-phase-of-trials Share FacebookTwitterPinterestWhatsApp Previous articleSPH stands ready to continue on its own if shareholders do not approve privatisation offersNext articleDutch weigh options to slow rising COVID-19 infections among children Latest Articles Delivery rider blind in one eye loses bid for $500 monthly maintenance from ex-wife 2026-10-28 Sea freight, postal service providers in S’pore charging more after Middle East conflict: Singstat 2026-10-28 SGX RegCo issues fresh queries to listed agribusiness companies over Indonesia fires and haze 2026-10-28 Billionaire Ambani’s Jio to debut after record India IPO 2026-10-27 Nearly 90% of businesses are turning to tokenised money, DBS survey shows 2026-10-27 Anthropic’s record IPO faces some big questions 2026-10-27